HIGHLIGHTS
- who: Psychopharmacology and collaborators from the Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behavior, RUNMC Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands have published the research: Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges, in the Journal: (JOURNAL)
- what: The pharmacovigilance study within PERS is aimed at filling in the safety knowledge gap, through conducting an observational open-label study in which 600 children and adolescents aged between 5 and 16 years who have been prescribed risperidone will be followed over a treatment period of up to 2 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.